Skip to main content
Top
Published in: Hepatology International 3/2012

01-06-2012 | Original Article

Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients

Authors: Daisuke Yoshida, Yoshihiro Nagao, Morimasa Tomikawa, Hirofumi Kawanaka, Tomohiko Akahoshi, Nao Kinjo, Hideo Uehara, Naotaka Hashimoto, Makoto Hashizume, Yoshihiko Maehara

Published in: Hepatology International | Issue 3/2012

Login to get access

Abstract

Purpose

The purpose of our study was to investigate predictive factors for platelet count at 1 month after splenectomy in patients with liver cirrhosis.

Methods

A total of 60 patients with liver cirrhosis who were treated with splenectomy from January 2005 to December 2006 were enrolled in the study (hepatitis C, n = 50; hepatitis B, n = 6; alcoholism, n = 2; others, n = 2). Various preoperative clinical characteristics, including spleen weight, were analyzed by simple and multiple linear regressions to study the relationship between platelet count before and after splenectomy.

Results

Platelet count increased significantly after splenectomy. After simple linear regression, spleen weight, preoperative platelet count, lymphocyte count, and total bilirubin were significantly correlated with platelet count after splenectomy. Spleen weight, preoperative platelet count, and lymphocyte count also had a significant correlation after multiple linear regression analysis.

Conclusions

Platelet count after splenectomy in cirrhotic patients can be predicted on the basis of preoperative clinical characteristics. When selecting patients for splenectomy, spleen weight, preoperative platelet count, and lymphocyte count should be taken into consideration.
Literature
1.
go back to reference Hayashi PH, Mehia C, Joachim Reimers H, Solomon HS, Bacon BR. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol 2006;40:740–744PubMedCrossRef Hayashi PH, Mehia C, Joachim Reimers H, Solomon HS, Bacon BR. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol 2006;40:740–744PubMedCrossRef
2.
go back to reference Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 2008;38:1159–1171PubMed Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 2008;38:1159–1171PubMed
3.
go back to reference Hayashi H, Beppu T, Masuda T, et al. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 2007;22:1638–1642PubMedCrossRef Hayashi H, Beppu T, Masuda T, et al. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 2007;22:1638–1642PubMedCrossRef
4.
go back to reference Akwari OE, Itani KM, Coleman RE, Rosse WF. Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results. Ann Surg 1987;206:529–541PubMedCrossRef Akwari OE, Itani KM, Coleman RE, Rosse WF. Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results. Ann Surg 1987;206:529–541PubMedCrossRef
5.
go back to reference Tomikawa M, Akahoshi T, Sugimachi K, et al. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol 2010;25:397–402PubMedCrossRef Tomikawa M, Akahoshi T, Sugimachi K, et al. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol 2010;25:397–402PubMedCrossRef
6.
go back to reference Kawanaka H, Akahoshi T, Kinjo N, et al. Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg 2009;16:749–757PubMedCrossRef Kawanaka H, Akahoshi T, Kinjo N, et al. Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg 2009;16:749–757PubMedCrossRef
7.
go back to reference Hashizume M, Tanoue K, Akahoshi T, et al. Laparoscopic splenectomy: the latest modern technique. Hepatogastroenterology 1999;46:820–822PubMed Hashizume M, Tanoue K, Akahoshi T, et al. Laparoscopic splenectomy: the latest modern technique. Hepatogastroenterology 1999;46:820–822PubMed
8.
go back to reference Kawanaka H, Akahoshi T, Kinjo N, et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010;251:76–83PubMedCrossRef Kawanaka H, Akahoshi T, Kinjo N, et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010;251:76–83PubMedCrossRef
9.
go back to reference Kinjo N, Kawanaka H, Akahoshi T, et al. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 2010;97:910–916PubMedCrossRef Kinjo N, Kawanaka H, Akahoshi T, et al. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 2010;97:910–916PubMedCrossRef
10.
go back to reference Akahoshi T, Tomikawa M, Korenaga D, et al. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg Endosc 2010;24:680–685PubMedCrossRef Akahoshi T, Tomikawa M, Korenaga D, et al. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg Endosc 2010;24:680–685PubMedCrossRef
11.
go back to reference Katz SC, Pachter HL. Indications for splenectomy. Am Surg 2006;72:565–580PubMed Katz SC, Pachter HL. Indications for splenectomy. Am Surg 2006;72:565–580PubMed
12.
13.
go back to reference Fabris F, Zanatta N, Casonato A, et al. Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. Acta Haematol 1989;81:28–33PubMedCrossRef Fabris F, Zanatta N, Casonato A, et al. Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. Acta Haematol 1989;81:28–33PubMedCrossRef
14.
go back to reference DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ. Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 1980;69:430–442PubMedCrossRef DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ. Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 1980;69:430–442PubMedCrossRef
15.
go back to reference Katkhouda N, Grant SW, Mavor E, et al. Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura. Surg Endosc 2001;15:484–488PubMedCrossRef Katkhouda N, Grant SW, Mavor E, et al. Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura. Surg Endosc 2001;15:484–488PubMedCrossRef
16.
go back to reference Duperier T, Brody F, Felsher J, et al. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg 2004;139:61–66 (discussion 6)PubMedCrossRef Duperier T, Brody F, Felsher J, et al. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg 2004;139:61–66 (discussion 6)PubMedCrossRef
17.
go back to reference McCormick PA, Walker S, Benepal R. Hypersplenism is related to age of onset of liver disease. Ir J Med Sci 2007;176:293–296PubMedCrossRef McCormick PA, Walker S, Benepal R. Hypersplenism is related to age of onset of liver disease. Ir J Med Sci 2007;176:293–296PubMedCrossRef
18.
go back to reference Lee CM, Leung TK, Wang HJ et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 2007;13:619–622 Lee CM, Leung TK, Wang HJ et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 2007;13:619–622
19.
go back to reference Hayashi H, Beppu T, Okabe K et al. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol 2010;45:554–559 Hayashi H, Beppu T, Okabe K et al. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol 2010;45:554–559
20.
go back to reference Owen OE, Trapp VE, Reichard GA Jr, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983;72:1821–1832PubMedCrossRef Owen OE, Trapp VE, Reichard GA Jr, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983;72:1821–1832PubMedCrossRef
21.
go back to reference Nishida T, Sakakibara H. Low lymphocyte count in underweight Japanese women. Environ Health Prev Med 2008;13:345–348PubMedCrossRef Nishida T, Sakakibara H. Low lymphocyte count in underweight Japanese women. Environ Health Prev Med 2008;13:345–348PubMedCrossRef
22.
go back to reference Seltzer MH, Bastidas JA, Cooper DM, et al. Instant nutritional assessment. JPEN J Parenter Enteral Nutr 1979;3:157–159PubMedCrossRef Seltzer MH, Bastidas JA, Cooper DM, et al. Instant nutritional assessment. JPEN J Parenter Enteral Nutr 1979;3:157–159PubMedCrossRef
23.
go back to reference Dzieniszewski J, Jarosz M, Szczygiel B, et al. Nutritional status of patients hospitalised in Poland. Eur J Clin Nutr 2005;59:552–560PubMedCrossRef Dzieniszewski J, Jarosz M, Szczygiel B, et al. Nutritional status of patients hospitalised in Poland. Eur J Clin Nutr 2005;59:552–560PubMedCrossRef
24.
go back to reference Nakaya Y, Okita K, Suzuki K, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007;23:113–120PubMedCrossRef Nakaya Y, Okita K, Suzuki K, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007;23:113–120PubMedCrossRef
Metadata
Title
Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients
Authors
Daisuke Yoshida
Yoshihiro Nagao
Morimasa Tomikawa
Hirofumi Kawanaka
Tomohiko Akahoshi
Nao Kinjo
Hideo Uehara
Naotaka Hashimoto
Makoto Hashizume
Yoshihiko Maehara
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 3/2012
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-011-9315-6

Other articles of this Issue 3/2012

Hepatology International 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.